ID/EIS Joint Fellowship
The ID/EIS Joint Fellowship is not accepting any new applicants at this time.
IDSA, in partnership with CDC, has created a joint infectious diseases and CDC Epidemic Intelligence Service fellowship pilot program for physicians pursuing an ID fellowship.
The ID/EIS training program combines the two-year ID fellowship and two-year EIS program for a structured four-year training opportunity.
The ID/EIS joint fellowship provides an unmatched opportunity for physicians interested in infectious diseases to expand their public health training, serve on the frontlines of global outbreaks and join an esteemed network of more than 4,000 EIS alumni, including state public health officials, CDC directors, acting surgeons general, WHO assistant directors-general and more.
Let’s Talk ID | President’s Podcast
ID/EIS program leaders discuss the joint fellowship in this Let’s Talk ID episode. IDSA President Carlos del Rio, MD, FIDSA, speaks with Molly Paras, MD, FIDSA, program director of the Massachusetts General Hospital/Brigham and Women’s Hospital Infectious Diseases Fellowship, and Eric Pevzner, PhD, MPH, chief of the Epidemiology and Laboratory Workforce Branch in the Division of Workforce Development at CDC, about the joint fellowship and the value it will bring to public health.
Background
Funded by CDC, the joint ID/EIS fellowship pilot program is developing future public health leaders. The four-year ID/EIS fellowship program begins with a two-year ID fellowship then continues with the two-year EIS program. During the EIS training, joint fellows will directly address public health threats, working either in field locations at state and local public health departments or at the CDC headquarters in Atlanta.
Eleven ID fellowship programs, listed below, are currently participating in the ID/EIS pilot. Additional programs will be added in the future.
The Joint ID/EIS Fellowship Program
There are several benefits to the joint ID/EIS Fellowship program for applicants:
Convenience
Location
Incorporation
Applicant & program information
Information for Joint ID/EIS Applicants
This new opportunity pairs an ID fellowship with the EIS program. For the first year of the pilot, 11 ID fellowship programs were selected to participate in the pilot. Learn about the programs and the application process by clicking below.
Applications are not currently being accepted to the joint program but may be in the future.
Information for ID Fellowship Programs
The competitive application process to become part of the joint fellowship has closed for calendar year 2023. Selected ID fellowship programs were notified in June 2023.
IDSA and CDC may expand the number of participating programs in future years. If the pilot is expanded further, a competitive application process will be held, with updates shared on this website.
More information for ID fellowship programs can be found by clicking below.
Pilot timeline
Applications for the first cohort of fellows are expected to open in early spring 2023 for placement in two-year ID programs in July 2024. This first cohort will then join the EIS class of 2026. Each year a new cohort will be welcomed into the joint fellowship by beginning an ID fellowship.
2022
ID Fellowship Programs selected to participate in the join ID/EIS pilot (early 2022)
2023
Applications open for candidates to apply to join ID/EIS fellowship (Spring 2023)
2024
Cohort 1 Accepted Fellows begin ID portion of the joint fellowship (July 2024)
2026
Cohort 1 Accepted Fellows begin EIS portion of the joint fellowship - join EIS class of 2026 (July 2026)
2028
Cohort 1 Accepted Fellows complete EIS portion of the joint fellowship (June 2028)
The joint ID/EIS fellowship pilot program is funded by a cooperative agreement with the Centers for Disease Control and Prevention (grant number NU50CK000574). The Centers for Disease Control and Prevention is an agency within the Department of Health and Human Services (HHS). The information on this page does not necessarily represent the policy of CDC or HHS, and should not be considered an endorsement by the Federal Government.